Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIC-19: Platelet Inhibition With GP IIb/IIIa Inhibitor in Critically Ill COVID-19 Patients
NCT04368377Phase 2Completed
- Sponsor
- University of Milan
- Start
- Apr 2020
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirofiban in coronavirus disease 2019 (COVID-19), pneumonia, respiratory failure, thrombosis, sponsored by University of Milan. Started Apr 2020; status: completed.
02
Drugs
tirofiban
03
Conditions
coronavirus disease 2019 (COVID-19)pneumoniarespiratory failurethrombosis
Beyond the preview
Go deeper on NCT04368377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04368377.